How Does AstraZeneca's Covid-19 Vaccine Compare With Pfizer-BioNTech?

The AstraZeneca/Oxford vaccine's efficacy in preventing symptomatic infections was 70.4%, according to interim data, after 30 of 5,807 people who got the two-dose vaccine developed COVID-19, compared with 101 of 5,829 people who got a placebo.

from Top World News- News18.com https://ift.tt/38W5GEH